Morgan Stanley’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.74M | Buy |
534,621
+284,102
| +113% | +$1.45M | ﹤0.01% | 4508 |
|
|
2025
Q1 | $343K | Sell |
250,519
-69,551
| -22% | -$95.3K | ﹤0.01% | 5505 |
|
|
2024
Q4 | $989K | Sell |
320,070
-21,907
| -6% | -$67.7K | ﹤0.01% | 5095 |
|
|
2024
Q3 | $2.63M | Buy |
341,977
+98,608
| +41% | +$759K | ﹤0.01% | 4458 |
|
|
2024
Q2 | $2.09M | Buy |
243,369
+63,850
| +36% | +$548K | ﹤0.01% | 4535 |
|
|
2024
Q1 | $1.43M | Sell |
179,519
-107,295
| -37% | -$852K | ﹤0.01% | 4769 |
|
|
2023
Q4 | $2.84M | Buy |
286,814
+93,490
| +48% | +$926K | ﹤0.01% | 4742 |
|
|
2023
Q3 | $2.18M | Buy |
193,324
+139,130
| +257% | +$1.57M | ﹤0.01% | 4344 |
|
|
2023
Q2 | $180K | Sell |
54,194
-21,397
| -28% | -$71K | ﹤0.01% | 5691 |
|
|
2023
Q1 | $299K | Buy |
75,591
+46,672
| +161% | +$184K | ﹤0.01% | 5517 |
|
|
2022
Q4 | $210K | Buy |
28,919
+5,753
| +25% | +$41.7K | ﹤0.01% | 5652 |
|
|
2022
Q3 | $83K | Buy |
23,166
+4,734
| +26% | +$17K | ﹤0.01% | 6175 |
|
|
2022
Q2 | $84K | Buy |
18,432
+2,717
| +17% | +$12.4K | ﹤0.01% | 6365 |
|
|
2022
Q1 | $119K | Buy |
15,715
+6,878
| +78% | +$52.1K | ﹤0.01% | 6218 |
|
|
2021
Q4 | $96K | Buy |
8,837
+6,990
| +378% | +$75.9K | ﹤0.01% | 6468 |
|
|
2021
Q3 | $24K | Buy |
+1,847
| New | +$24K | ﹤0.01% | 7039 |
|